Blog
RSS FeedPosted by Michael Wonder on 21 Apr 2017
Proposal for various medicines in the neurology, immunology and nephrology therapeutic areas
21 April 2017 - PHARMAC is seeking feedback on a proposal relating to certain medicines in the neurology, immunology and ...
Posted by Michael Wonder on 05 Apr 2017
Listing on the Pharmaceutical Schedule of a range of orthopaedic implants and associated products with LMT Surgical Pty Ltd
5 April 2017 - PHARMAC is pleased to announce the approval of a listing agreement for the supply of orthopaedic ...
Posted by Michael Wonder on 09 Mar 2017
Proposal to list a range of orthopaedic implants and associated products supplied by LMT Surgical Pty Ltd
9 March 2017 - PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated ...
Posted by Michael Wonder on 28 Feb 2017
New Zealand Pharmaceutical Schedule - 1 March 2017
1 March 2017 - The March 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Feb 2017
Additional listings on the Pharmaceutical Schedule of a range of orthopaedic implants and associated products with Smith and Nephew Limited
27 February 2017 - PHARMAC is pleased to announce the approval of an amendment to the trauma agreement with Smith ...
Posted by Michael Wonder on 21 Feb 2017
Massive support for NZ drug-buying agency PHARMAC to fund pads and tampons
21 February 2017 - Nearly 10,000 people have responded to a 1 NEWS Facebook poll that asked if tampons and sanitary ...
Posted by Michael Wonder on 02 Feb 2017
Proposal to list orthopaedic hip and knee implants, cement and associated products on the Pharmaceutical Schedule
2 February 2017 - PHARMAC is seeking feedback on a proposal to list further ranges of orthopaedic implants and associated ...
Posted by Michael Wonder on 31 Jan 2017
New Zealand Pharmaceutical Schedule - 1 February 2017
1 February 2017 - The February 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Jan 2017
New Zealand Pharmaceutical Schedule - 1 January 2017
1 January 2017 - The January 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 14 Dec 2016
Somatropin for patients under 2 years with Prader-Willi Syndrome
14 December 2016 - PHARMAC is pleased to announce that somatropin (human growth hormone) will be fully funded for patients ...
Posted by Michael Wonder on 30 Nov 2016
New Zealand Pharmaceutical Schedule - 1 December 2016
1 December 2016 - The December 2016 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 16 Nov 2016
Proposal to list oral betaine for rare disorder
16 November 2016 - PHARMAC is seeking feedback on a proposal to list betaine (Cystadane) resulting from a provisional agreement ...
Posted by Michael Wonder on 14 Nov 2016
Decision to list enzyme replacement therapies for some rare disorders
11 November 2016 - PHARMAC is pleased to announce the approval of an agreement with Sanofi-Aventis for the listing of ...
Posted by Michael Wonder on 31 Oct 2016
New Zealand Pharmaceutical Schedule - 1 November 2016 update
1 November 2016 - The November 2016 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 28 Oct 2016
Update on proposed changes to 2nd & 3rd line anti-VEGF treatments for ophthalmic use
28 October 2016 - On 5 September 2016, PHARMAC consulted on a proposal to list ranibizumab (Lucentis) and aflibercept (Eylea) ...